Paranta Biosciences
Caulfield, Victoria, Australia
About Paranta Biosciences
Paranta Biosciences is an early stage drug development company committed to developing and commercializing novel biotherapeutics based on recombinant human follistatin to treat conditions involving inflammation and fibrosis. A key therapeutic focus for the company is the treatment of respiratory diseases. However we are keen to explore partnering opportunities to assist with development of follistatin to treat other inflammatory and fibrotic conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $4.9M
- Last round: Series Unknown (Oct 2015)
- Website: parantabio.com
- Phone: (039)526-0021
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/paranta-biosciences-2462299 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.